Do recombinant human erythropoietin and iron supplementation increase the risk of retinopathy of prematurity?
Eur J Pediatr
; 159(8): 627-8, 2000 Aug.
Article
em En
| MEDLINE
| ID: mdl-10968244
ABSTRACT
Comparing a group of infants treated with recombinant erythropoietin and iron supplementation to a group of control infants, no difference was observed concerning the transfusion need. The incidence of retinopathy of prematurity was significantly higher in the treated group. These data need to be confirmed in randomized controlled studies.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Retinopatia da Prematuridade
/
Compostos Férricos
/
Eritropoetina
Tipo de estudo:
Clinical_trials
/
Diagnostic_studies
/
Etiology_studies
/
Incidence_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Humans
/
Newborn
Idioma:
En
Revista:
Eur J Pediatr
Ano de publicação:
2000
Tipo de documento:
Article